1George J,Barsheshet A,Moss AJ,et al.Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy.Ann Noninvasive Electrocardiol,2012,17:14-21.
2Shalaby A,Brumberg G,El-Saed A,et al.mood disorders and outcome in patients receiving cardiac resynchronization therapy.pacing clin electrophysiol,2012 Jan 9.doi:10.1111/j.1540-8159.2011.03304.x.
3Jons C,Thomsen PE.Treating cardiac arrhythmias detected with an implantable cardiac monitor in patients after an acute myocardial infarction.Curr Treat Options Cardiovasc Med,2012,14:39-49.
5Epstein AJ,Polsky D,Yang F,et al.Groeneveld PW.Geographic variation in implantable cardioverter-defibrillator use and heart failure survival.Med Care,2012,50:7-10.
6Gasparini M,Galimberti P,Ceriotti C.The values of defibrillation testing at implantable cardioverter defibrillator implantation:′and then there were none′.Curr Opin Cardiol,2012,27:8-12.
7Thijssen J,Borleffs CJ,Delgado V,et al.Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.J Am Coll Cardiol,2011,58:2282-2289.
8Perrotta L,Ricciardi G,Pieragnoli P,et al.Application of the Seattle heart failure model in patients on cardiac resynchronization therapy.Pacing Clin Electrophysiol,2012,35:88-94.
9Scott PA,Whittaker A,Zeb M,et al.Rates of Upgrade of ICD Recipients to CRT in Clinical Practice and the Potential Impact of the More Liberal Use of CRT at Initial Implant.Pacing Clin Electrophysiol,2012,35:73-80.
10Sack S,Wende CM,Ngele H,et al.Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events:results from Home-CARE(Home Monitoring in Cardiac Resynchronization Therapy)study.Eur J Heart Fail,2011,13:1019-1027.